Eli Lilly and Company

Senior Director - Construction and Engineering Services Capital Procurement

United States

Eli Lilly and Company Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Pharmaceuticals, Construction, Engineering, Capital ProjectsIndustries

Requirements

Candidates should possess a Bachelor’s degree in Construction Management, Engineering, or a related field, along with a minimum of 10 years of experience in construction procurement, preferably within the pharmaceutical or life sciences industry. Demonstrated expertise in negotiating complex construction service agreements is essential, as is experience managing mega industrial projects. Strong knowledge of capital project delivery methodologies and a deep understanding of construction cost control principles are also required.

Responsibilities

The Senior Director - Construction and Engineering Services Capital Procurement will lead and manage procurement strategies for a portfolio of large-scale capital projects, developing and maintaining strategic relationships with key suppliers such as Construction Managers, Design Builders, and EPC/EPCMs. This role involves negotiating and finalizing billion-dollar contracts, driving supplier development initiatives, collaborating with internal stakeholders, and ensuring compliance with regulations and standards. The position also requires monitoring market trends, identifying cost savings opportunities, and influencing senior management on key procurement decisions.

Skills

Construction service agreements
Mega industrial projects
Capital procurement
Strategic supplier relationships
Negotiation
Contract management
Stakeholder collaboration
Market trend analysis
Cost savings and efficiency

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Key Metrics

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI